Inaktiver Wert

Andere Sprachen Opexa Therapeutics Inc Nasdaq

Aktien

US68372T3014

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Acer Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	20.11.
Chris Schelling Ceases to Be Chief Executive Officer of Acer Therapeutics Inc	20.11.
Harry S. Palmin Ceases to Be Chief Financial Officer of Acer Therapeutics Inc	20.11.
Acer Therapeutics Inc. Announces Executive Changes	20.11.
Zevra Therapeutics Completes Acer Acquisition	20.11.
Zevra Therapeutics, Inc. completed the acquisition of Acer Therapeutics Inc. from funds affiliated with TVM Capital Life Science and others.	17.11.
Acer Therapeutics Inc.(OTCPK:ACER) dropped from S&P TMI Index	13.11.
Acer Therapeutics Inc.(OTCPK:ACER) dropped from NASDAQ Composite Index	08.11.
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals	02.11.
ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER	10.10.23
North American Morning Briefing : Inflation -2-	06.09.23
ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER	06.09.23
North American Morning Briefing : Chinese Data -2-	05.09.23
Top Midday Decliners	01.09.23
Sector Update: Health Care Stocks Lower in Late Afternoon Trading	31.08.23
Sector Update: Health Care	31.08.23
Top Midday Gainers	31.08.23
Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra	31.08.23
ACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to Shareholders	31.08.23
Zevra Therapeutics to Acquire Acer Therapeutics in Merger Deal	31.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Opexa Therapeutics Inc Nasdaq

Aktien

US68372T3014

Andere Sprachen

Filter